[{"data":1,"prerenderedAt":-1},["ShallowReactive",2],{"health-study-detail:100589618":3},{"organization":4,"armGroups":7,"interventions":7,"overallOfficials":7,"centralContacts":8,"locations":18,"responsibleParty":36,"collaborators":7,"id":38,"slug":7,"hasResults":39,"nctId":40,"briefTitle":41,"officialTitle":41,"acronym":7,"eligibilityCriteria":42,"healthyVolunteers":39,"sex":43,"minAge":44,"maxAge":7,"enrollmentInfo":45,"targetDuration":48,"studyType":49,"phases":7,"briefSummary":50,"conditions":51,"keywords":54,"overallStatus":21,"whyStopped":7,"lastUpdateSubmitDate":57,"lastUpdatePostDateStruct":58,"startDateStruct":61,"completionDateStruct":63,"leadSponsor":65,"locationsCount":66},{"fullName":5,"class":6},"Groupe Francophone des Myelodysplasies","OTHER",null,[9,14],{"name":10,"role":11,"phone":12,"phoneExt":7,"email":13},"Fatiha CHERMAT, PhD","CONTACT","+33(0)1 71 20 70 59","fatiha.chermat-ext@aphp.fr",{"name":15,"role":11,"phone":16,"phoneExt":7,"email":17},"Pierre FENAUX, Pr","+33 (0) 1 71 20 78 18","pierre.fenaux@aphp.fr",[19],{"facility":20,"status":21,"city":22,"state":7,"zip":23,"country":24,"cosmosGeoPoint":25,"geoPoint":30,"contacts":31},"Aspasia Stamatoullas","RECRUITING","Rouen","76038","France",{"type":26,"coordinates":27},"Point",[28,29],1.09932,49.44313,{"lat":29,"lon":28},[32],{"name":33,"role":11,"phone":34,"phoneExt":7,"email":35},"aspasia stamatoullas, MD","02 32 08 22 88","spasia.stamatoullas@chb.unicancer.fr",{"type":37,"investigatorFullName":7,"investigatorTitle":7,"investigatorAffiliation":7,"oldNameTitle":7,"oldOrganization":7},"SPONSOR","100589618",false,"NCT06956755","Registry of Myelodysplastic Syndromes and Therapy-related Acute Myeloid Leukemia","Inclusion Criteria:\n\n* Male or female\n* Age \\> 18 years\n* Patients with myelodysplastic syndrome and therapy-related acute myeloid leukemia\n* Able and willing to provide written informed consent\n\nExclusion Criteria:\n\n* Age \\\u003C18 years\n* Patient is unwilling or unable to give consent","ALL","18 Years",{"count":46,"type":47},6990,"ESTIMATED","6 Months","OBSERVATIONAL","The Registry MDS is an ongoing, observational study that has collected longitudinal data on diagnostics, demographics, clinical parameters, and health Care Interventions (HCI) from patients with MDS and therapy-related acute myeloid leukemia",[52,53],"Myelodysplastic Syndromes","Leukemia, Myeloid, Acute",[55,56],"MDS","t-AML","2025-05-02",{"date":59,"type":60},"2025-05-06","ACTUAL",{"date":62,"type":60},"2003-07-07",{"date":64,"type":47},"2031-01-05",{"name":5,"class":6},1]